<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Pharmaceutical Industry on FinanClub</title>
    <link>https://finan.club/tags/pharmaceutical-industry/</link>
    <description>Recent content in Pharmaceutical Industry on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Sat, 02 Sep 2023 03:02:17 +0000</lastBuildDate><atom:link href="https://finan.club/tags/pharmaceutical-industry/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>JNJ</title>
      <link>https://finan.club/us/jnj/</link>
      <pubDate>Sat, 02 Sep 2023 03:02:17 +0000</pubDate>
      
      <guid>https://finan.club/us/jnj/</guid>
      <description>score:-6
Chances: Johnson &amp;amp; Johnson Forecasts Double-Digit Earnings Growth After Kenvue Spin-Off Johnson &amp;amp; Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation Why Johnson &amp;amp; Johnson (JNJ) is a Great Dividend Stock Right Now J&amp;amp;J’s Kenvue Exchange Offer Was a Big Win for the Little Guy Ken Fisher’s Top 15 Healthcare Stock Picks Risks: Johnson &amp;amp; Johnson Just Cut an Entire Division.</description>
    </item>
    
  </channel>
</rss>
